Commercial Credit Report for Icares Medicus Inc

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Icares Medicus Inc is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

	Icares Medicus Inc
4F, No.16, Section 2, Sheng Yi Road
Phone: +886 36579530p:+886 36579530	ZHUBEI, 302 Taiwan	Ticker: 66126612

Business Summary

Icares Medicus Inc is a Taiwan-based company mainly engaged in the authorization of high-end medical material surface treatment technology. The Company is also involved in the sale of surface treatment formulations and provision of customer surface treatment processing services, as well as the research and development, manufacture and sale of artificial lens and its implantation system. The Company's product revenue is mainly divided into three categories. The royalty income comes from the authorization of implantation/invasive high-end medical material surface treatment technology. The technical service income mainly includes implantation/invasive high-end medical surface treatment services, provision of medical coatings and foundry of artificial lens implantation systems. The sales of medical materials mainly include the sales of medical materials surface inspection equipment and other products. The Company distributes its products in domestic and overseas markets.

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
Yes	Yes	-	-	-	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
12/31/2023	12/31/2023	Yes	-	-	-	-

Industries

SIC Code	Description
3851	Ophthalmic goods
3841	Surgical and medical instruments and apparatus
3842	Orthopedic, prosthetic, and surgical appliances and supplies

Officers and Directors

Title	Name	Title Date	Start Date
Chairman of the Board, Group Chief Executive Officer	Ih-HoungLoh	7/1/2019
Vice Chairman of the Board, Group Chief Research & Development Officer	Wen-ChuTseng	7/1/2019	6/25/2019
Group Chief Financial Officer, Head of Finance & Accounting, Corporate Governance Officer	Tan-LiChen	4/17/2024
7 additional Officers and Directors records available in full report.

General Information

Number of Employees:	27	(As of 12/31/2014)
Outstanding Shares:	39,160,000	(As of 12/31/2023)
Shareholders:	2,138
Stock Exchange:	TPO
Fax Number:	+886 36579533

SITE MAP | ABOUT US | DIRECTORY | STOCK QUOTE: CRMZ | SIGN IN